- Ownership hops held
- 45
An absent edge means not yet observed — never does not exist.
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. — US company (sec:0001750149). UBO chain traced 45 hops, 5 owners. Every claim linked to its source.
Ownership resolves 45 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Inhibikase Therapeutics, Inc.
None in current sources.
45-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on Inhibikase Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.
- UBO traceDOSSIER
- Live adverse-media scan on unlockDOSSIER
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
3 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Adverse-media & person enrichmentDOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
13 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- Aurentz VincentAlso holds roles at 3 other companies
- LONGBOARD PHARMACEUTICALS, INC.director
- ARENA PHARMACEUTICALS INCofficer
- COMBINATORX INCofficer
- BERMAN DENNIS NAlso holds roles at 6 other companies
- KINTERA INCtenpercentowner
- KINTERA INCofficer
- KINTERA INCdirector
- Cabell ChristopherAlso holds roles at 3 other companies
- Zura Bio Ltdofficer
- PULMATRIX, INC.director
- ARENA PHARMACEUTICALS INCofficer
- GRINT PAUL CAlso holds roles at 5 other companies
- Armata Pharmaceuticals, Inc.director
- Armata Pharmaceuticals, Inc.officer
- Regulus Therapeutics Inc.director
- Iwicki Mark TAlso holds roles at 11 other companies
- Q32 Bio Inc.director
- KALA BIO, Inc.officer
- KALA BIO, Inc.director
- MCINTYRE DAVIDAlso holds roles at 2 other companies
- AVITA Medical, Inc.officer
- HEARTWARE INTERNATIONAL, INC.officer
- Munshi AmitAlso holds roles at 9 other companies
- Zura Bio Ltddirector
- Arcutis Biotherapeutics, Inc.director
- Galecto, Inc.director
- O'FARRELL ELIZABETH G.Also holds roles at 4 other companies
- LENSAR, Inc.director
- GERON CORPdirector
- SPYGLASS OPHTHALMICS, INC.director
13 parties · 0 current. Ceased and resigned records are retained as history.
Adverse media
Live scan on unlockA live GDELT news scan for this entity's name (last 18 months) runs the moment you unlock. Matches are investigative leads by name and may come back empty.
Common questions
- Who owns Inhibikase Therapeutics, Inc.?
- What is Inhibikase Therapeutics, Inc.'s risk level?
- Where does Inhibikase Therapeutics, Inc. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for Inhibikase Therapeutics, Inc. — nothing is disclosed before that.